ANTIDIABETIC EFFECTS OF -GINGEROL IN STREPTOZOTOCIN- AND HIGH-FAT DIET-INDUCED DIABETIC RATS
Objective: India is the “diabetes capital of the world” with 62.4 million Indians having type 2 diabetes in 2011. A major risk factor for insulin resistance is obesity, which is generally caused by regular physical inactivity and high-fat diet (HFD). Obesity and diabetes are closely related to each other as about 80% of diabetics are obese. Obesity is a common finding in type 2 diabetes. The objective of the study was to investigate the antidiabetic effects of -gingerol in streptozotocin (STZ)- and HFD-induced diabetic rats.
Methods: Wistar rats were used for the study. Animals were divided into six groups. The six groups in this study were, Group I (normal control), Group II (diabetic control), Group III (glibenclamide at 5 mg/kg p.o.), Group IV (orlistat at 60 mg/kg p.o.), Group V (-gingerol at 15 mg/kg p.o.), and Group VI -gingerol (30 mg/kg p.o.), respectively. The antidiabetic activity was assessed using blood glucose level, body weight, and various biochemical parameters such as serum total cholesterol (TC) level, triglyceride (TG) level, high-density lipoproteins (HDLs), total protein (TP), serum alanine transaminase, and aspartate aminotransferase (serum glutamic-oxaloacetic transaminase), respectively.
Results: -gingerol exhibited an antidiabetic effect by significantly decreased the level of blood glucose, body weight, TC, TG, TP, and increase HDL. The results of the study demonstrated that the treatment with -gingerol significantly (p<0.05) and dose dependently prevented STZ- and HFD-induced diabetic rats.
Conclusions: The findings of the study suggest that -gingerol possesses potential antidiabetic activity as it lowers serum glucose level.
2. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for Type 2 diabetes and pharmacological screening. Pharmacol Res 2005;52:313-20.
3. Bhandaria U, Chaudharia HS, Khannab G, Najmi AK. Antidiabetic effects of Embelia ribes extract in high fat diet and low dose streptozotocin-induced Type 2 diabetic rats. Front Life Sci 2013;7:186-96.
4. Palou M, Sánchez J, Rodríguez AM, Priego T, Picó C, Palou A, et al. Induction of NPY/AgRP orexigenic peptide expression in rat hypothalamus is an early event in fasting: Relationship with circulating leptin, insulin and glucose. Cell Physiol Biochem 2009;23:115-24.
5. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 1996;104:293-300.
6. Flier JS. Obesity wars: Molecular progress confronts an expanding epidemic. Cell 2004;116:337-50.
7. Mohamed GA, Ibhramin SR, Elkhayat ES, Dine RS. Natural antiobesity agent. Bull Fac Pharm Cairo Univ 2014;52:269-84.
8. Zhang F, Ma N, Gao YF, Sun LL, Zhang JG. Therapeutic effects of 6-gingerol, 8-gingerol, and 10-gingerol on dextran sulfate sodium-induced acute ulcerative colitis in rats. Phytother Res 2017;31:1427-32.
9. Soliman AM. Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat diet/streptozotocin. J Basic Appl Zool 2016;77:8-20.
10. Khandouzi N, Shidfar F, Rajab A, Rahideh T, Hosseini P, Mir Taheri M, et al. The effects of ginger on fasting blood sugar, hemoglobin a1c, apolipoprotein B, apolipoprotein a-I and malondialdehyde in Type 2 diabetic patients. Iran J Pharm Res 2015;14:131-40.
11. Wang J, Ryu HK. The effects of Momordica charantia on obesity and lipid profiles of mice fed a high-fat diet. Nutr Res Pract 2015;9:489-95.
12. Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov Today 2007;12:879-89.
13. Arvind K, Pradeepa R, Deepa R, Mohan V. Diabetes and coronary artery disease. Indian J Med Res 2002;116:163-76.
14. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl 2002;3:47-51.
15. Nagarajan NS, Murugesh N, Thirupathy Kumaresan P, Radha N, Murali A. Antidiabetic and antihyperlipemic effects of clemeo felina. Fitoterapia 2005;76:310-5.
16. Pari L, Saravanan R. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats. Diabetes Obes Metab 2004;6:286-92.
17. Luo Q, Cai Y, Yan J, Sun M, Corke H. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci 2004;76:137-49.
18. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci U S A 1981;78:5190-2.
19. Ahmed RG. The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system. Med J Islam World Acad Sci 2005;15:31-42.
20. Odetola AA, Akinloye O, Egunjobi C, Adekunle WA, Ayoola AO. Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats. Clin Exp Pharmacol Physiol 2006;33:808-12.
21. Nikkilä EA, Kekki M. Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism 1973;22:1-22.
22. Howard BV, Savage PJ, Bennion LJ, Bennett PH. Lipoprotein composition in diabetes mellitus. Atherosclerosis 1978;30:153-62.
23. Saad EA, Hassanien MM, Hagrasy MA, Radwan KH. Antidiabetic, hypolipidemic and antioxidant activities and protective effects of Punica granatum peels powder against pancreatic and hepatic tissues injuries in streptozotocin induced IDDM in rats. Int J Pharm Pharm Sci 2015;7:397-402.
24. Arumugam S, Natesan SK. Hypoglycemic effects of Barleria noctiflora fractions on high fat fed with low dose streptozotocin induced Type-2 diabetes in rats. Int J Pharm Pharm Sci 2016;8:193-200.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.